Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis

Published:2015-09-10 Issue:12 Volume:56 Page:1869-1875
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Umeda Yukihiro,Demura Yoshiki,Morikawa Miwa,Anzai Masaki,Kadowaki Maiko,Ameshima Shingo,Tsuchida Tatsuro,Tsujikawa Tetsuya,Kiyono Yasushi,Okazawa Hidehiko,Ishizaki Takeshi,Ishizuka Tamotsu

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference31 articles.

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

2. Classification and Natural History of the Idiopathic Interstitial Pneumonias

3. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

4. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

5. Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging Pulmonary Fibrosis and Treatment Efficacy In Vivo with Autotaxin-Specific PET Ligand [¹⁸F]ATX-1905;Molecular Pharmaceutics;2024-08-26

2. [68Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [18F]FDG PET and CT;Pharmaceuticals;2024-06-03

3. Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung;International Journal of Molecular Sciences;2023-12-25

4. Lung Cancer and Lung Transplantation;Current Pulmonology Reports;2023-01-28

5. Novel tracers for molecular imaging of interstitial lung disease: A state of the art review;Autoimmunity Reviews;2022-12